# M1618 Paper-Route Contour-Aware Candidate Objective Design Audit And Synthesis

## Summary

M1618 audits the M1617 contour-aware candidate objective design and synthesizes
the current `paper_route_clean_active_set_contour_mapping` branch before any
evaluator implementation.

Decision:

```text
contour_aware_candidate_objective_design_audit_continue_to_exact_evaluator
```

M1618 is process-only. It does not implement an evaluator, does not construct a
loss or objective config, does not update an actor, does not run PPO, does not
promote a checkpoint, and does not use private holdout.

## Evidence Summary

The branch after the M1608 synthesis produced a clean public candidate package:

```text
M1609 diagnostic-complete replay:
  primary clean rows: 39
  diagnostic rows: 232
  diagnostic dominated/control rows: 81
  diagnostic clean share: 0.008620689655172414

M1612 materialization:
  candidate rows: 39
  diagnostic guardrails: 232
  candidate source-edge count: 4
  max source-edge share: 0.3333333333333333

M1615 package export:
  candidate_corpus_exported: true
  training_corpus_exported: false
  loss_constructed: false
  objective_constructed: false
  positive_candidate_count: 39
  diagnostic_guardrail_count: 232
  positive_rows_all_clean: true
  diagnostic_rows_used_as_positive: false
  public_proof_metadata_complete: true

M1617 design:
  positive candidates and diagnostic guardrails are lexicographically separated
  diagnostics remain non-positive guardrails
  future exact evaluator requirements are explicit
  objective construction, actor update, training, PPO, promotion, private
  holdout, and level3 self-ID claims remain blocked
```

The evidence is useful for building an exact evaluator, but it is still a
public/narrow proof package rather than paper-level validation.

## M1617 Audit

M1617 satisfies the required guardrails:

```text
loss_constructed: false
objective_constructed: false
objective_config_written: false
training_corpus_exported: false
actor_update_started: false
training_started: false
ppo_used: false
promoted: false
private_holdout_used: false
actor_input_contract_changed: false
level3_self_id_claim_made: false
```

Role separation is explicit:

```text
positive_candidate rows:
  count: 39
  allowed future use: positive exact evaluator rows

diagnostic_guardrail rows:
  count: 232
  allowed future use: guardrail and contamination checks only
  allowed as positive rows: false
  positive weight: 0.0
```

M1617 did not route directly to training, PPO, promotion, or private holdout.
It routed to this audit/synthesis milestone before evaluator implementation,
which satisfies the M1617 manifest gate.

## Supported Claims

M1618 supports:

```text
M1617 is a clean design-only milestone;
positive candidate and diagnostic guardrail roles are separated;
the future evaluator can be implemented as a no-update exact evaluator;
the branch cadence has been synthesized before further narrow work;
one evaluator implementation is admitted as infrastructure, not driver progress.
```

## Falsified Or Rejected Claims

M1618 rejects:

```text
the M1615/M1617 package is training-ready;
diagnostic guardrails can be used as positive objective targets;
objective construction is already complete;
PPO or actor update is admitted now;
this public package is paper-level validation;
the driver has level3 anticipatory self-identification.
```

No scientific failure is introduced in M1618; the failure taxonomy remains:

```text
none
```

## Public-Gate Overfit Risk

Risk remains high:

```text
the positive package has only 39 public candidates;
source-edge count is 4;
the package has been produced through multiple public proof-row filters;
diagnostic guardrails are public controls, not private holdout;
an optimizer could overfit these rows without improving closed-loop behavior.
```

Mitigation:

```text
M1619 is no-update evaluator only;
M1619 must report role-integrity and diagnostic contamination metrics;
M1619 must not write objective_config.json or loss_config.json;
M1619 must prove checkpoint weights are unchanged;
any later objective update requires a separate M1619 result audit;
private holdout remains unused.
```

## Branch Synthesis Decision

The branch should continue, but only to one bounded no-update evaluator
implementation.

Decision:

```text
continue
```

Rationale:

```text
The branch has produced a coherent public candidate package and a conservative
objective design. The next useful evidence increment is not training; it is to
make the exact evaluator executable, finite, and mutation-safe. That evaluator
will determine whether the package has enough information for a policy-side
objective or only metadata/row-metric residuals.
```

Hard boundary:

```text
After M1619, run a result audit before any objective-only update, actor update,
PPO, promotion, private holdout, or paper-level claim.
```

## Next Branch Decision

Admit exactly one implementation milestone:

```text
m1619-paper-route-contour-aware-candidate-objective-evaluator-implementation
```

Scope:

```text
no-update exact evaluator/sanity checker only;
full M1615 package read;
positive/diagnostic roles preserved;
finite metric artifacts written;
checkpoint mutation guard checked;
no training/objective/loss config/checkpoint artifacts.
```

Unsupported next steps:

```text
objective-only update;
actor update;
PPO;
promotion;
private holdout;
actor input changes;
level3 self-identification claim.
```
